AI assistant
Sending…
Pulmonx Corp — Director's Dealing 2024
Mar 8, 2024
34428_dirs_2024-03-07_64b07502-8d18-4bfc-938c-d55c81381a6c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2024-03-01
Reporting Person: Rose Geoffrey Beran (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-01 | Common Stock | A | 69100 | — | Acquired | 309052 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | Employee Stock Option (right to buy) | $9.30 | A | 34500 | Acquired | 2034-02-28 | Common Stock (34500) | Direct |
Footnotes
F1: Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.
F2: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.
More from Pulmonx Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2025
Dec 11
Director's Dealing
2025
Dec 9
Regulatory Filings
2025
Dec 9
Director's Dealing
2025
Dec 4
Director's Dealing
2025
Dec 4